Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05488314 |
|---|---|
| Brief Title: | A Study of Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic Non-small Cell Lung Cancer (METalmark) |
| First Submitted : | August 3, 2022 |
| First Submitted that Met QC Criteria : | August 3, 2022 |
| First Posted : | August 4, 2022 |
| Last Update Submitted that Met QC Criteria : | April 23, 2024 |
| Last Update Posted : | April 24, 2024 |